CSL 150.59 -2.70 -1.76% Volume: 175,378 January 26, 2021 4:00 PM ET View more


CIT’s Medical Technologies unit designs, develops and manufactures custom interconnect assemblies for thousands of life enhancing medical devices.

Our Approach

Mergers and acquisitions have been a driving force behind Carlisle’s sustained growth over our history, including over 80 acquisitions in the past 30 years. In the past decade alone, we have deployed over $4 billion in order to build our four reporting segments. We seek synergistic acquisitions in core or adjacent markets. Characteristics of our investments include: highly specialized and highly engineered manufactured products; high performance, mission critical products designed to operate in harsh environments; and strong brands with leading market positions. Our current focus is to build out our Building Envelope, Architectural Metals and Polyurethane platforms within CCM, our Medical Technologies and Aerospace platforms within CIT, and our Sealants and Adhesives platform within CFT.

In 2019, we closed on seven acquisitions and announced an agreement to acquire an additional company.